The Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing market size is expected to reach $5.28 billion by 2030 at a CAGR of 6.0%, driven by increasing prevalence of hospital-acquired infections.
The Mepolizumab market size is expected to reach $3.21 billion by 2030 at a CAGR of 7.7%, driven by increasing global burden of asthma.
The Medical Instruments Disinfections market size is expected to reach $5.2 billion by 2030 at a CAGR of 8.5%, driven by increasing prevalence of healthcare-associated infections.
The Mastitis Control Products market size is expected to reach $2.65 billion by 2030 at a CAGR of 5.7%, driven by rising dairy production demand.